Genetic information, genomic technologies, and the future of drug discovery

JAMA

Volumn 285, Issue 5, 2001, Pages 551-555

  Bumol, Thomas F ^a   Watanabe, August M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; GENE TECHNOLOGY; GENETIC ANALYSIS; GENOME; HUMAN; MEDICAL RESEARCH; MOLECULAR GENETICS; PHARMACOGENETICS; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0035819466     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.5.551     Document Type: Article

References (49)

1. Implications of the Human Genome Project for medical science
2. Genomic sciences and the medicine of tomorrow
3. Analysis of expressed sequence tags indicates 35,000 human genes
4. Estimate of human gene number provided by genome-wide analysis using Tetraodon nigroviridis DNA sequence
5. Drug discovery: A historical perspective
6. Genomic biology
7. Equipping scientists for the new biology
8. Using bioinformatics in gene and drug discovery
9. Gene Expression analysis by transcript profiling coupled to a gene database query
10. High density synthetic oligonucleotide arrays
11. Genomics, gene expression and DNA arrays
12. Proteomics: A major new technology for the drug discovery process
13. Proteomics to study genes and genomes
14. Chromosomal localization and expressed sequence tag generation of clones from a normalized human adult thymus cDNA library
15. Suppression subtractive hybridization: A method for generating differentially regulate or tissue-specific cDNA probes and libraries
16. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae
17. Regulation of tyrosine kinase cascades by G-protein-coupled receptors
18. Drug discovery in the next millennium
19. Orphan G-protein-coupled receptors: The next generation of drug targets?
20. Gene Families: The taxonomy of protein paralogs and chimeras
21. Signaling 2000 and beyond
22. EST, Large-scale predictions of secretory proteins from mammalian genomic, sequences
23. Recombinant antibodies for the diagnosis and therapy of human disease
24. Leptin and the regulation of body weight in mammals
25. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling
26. Utilization of genetically altered animals in the pharmaceutical industry
27. The Role of the genome project in determining gene function: Insights from model organisms
28. High-throughput screening: Advances in assay technologies
29. New assay technologies for high-throughput screening
30. Combinatorial chemistry and contemporary pharmacology
31. Houghten RA, Parallel array and mixture-based synthetic combinatorial chemistry: Tools for the next millennium
32. Target-oriented and diversityoriented organic synthesis in drug discovery
33. High-avidity human IgGk monoclonal antibodies from a novel strain of minilocus transgenic mice
34. Novel antithrombotics based on modulation of the protein C pathway
35. Effects of Keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation
36. The roles of osteroprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
37. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
38. Anti-cytokine therapy for rheumatoid arthritis: Anti-cytokine therapy for rheumatoid arthritis
39. Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overspessing metastatic breast cancer
40. Medicinal strategies in the treatment of obesity
41. Pharmacological agents acting at subtypes of metabotropic glutamate receptors
42. Structure-based assignment of the biochemical function of a hypothetical protein: A test case of structural genomics
43. A gene expression database for the molecular pharmacology of cancer
44. Embryonic stem cell lines derived from human blastocysts
45. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
46. The use of singlenucleotide polymorphism maps in pharmacogenomics
47. Pharmacogenetics and the practice of medicine